Latest Headlines

1. Comecer To Exhibit Aseptic Filling Solutions At ISPE Annual Meeting 2025 10/17/2025

   Comecer will be exhibiting at the ISPE Annual Meeting & Expo 2025, on October 26 - 29 at the Charlotte Convention Center in North Carolina, USA.

2. Ensera Launches As New Brand Identity For SteriPack 10/14/2025

   New trading name reflects expanded expertise across design, manufacturing, assembly and packing for global pharma and medical device companies.

3. Jubilant HollisterStier LLC Launches New High-Speed Isolator Based Line, At Its Spokane Manufacturing Facility In The US 10/14/2025

   Jubilant Pharmova Limited announced today that Jubilant HollisterStier LLC (JHS)—a wholly owned subsidiary and a leading North American pharmaceutical contract manufacturer, specialising in sterile injectables and serving top global innovator pharma companies—successfully launched its New Sterile Fill & Finish line, third at its Spokane Manufacturing Facility in Washington, US. The launch was marked by the successful production of the inaugural batch, initiating revenue generation from the new Line. This milestone denotes a significant advancement in Jubilant HollisterStier's multi-phase expansion strategy and brings an additional 50% capacity at its Spokane manufacturing facility.

4. Ypsomed Investing $195M Into Holly Springs, NC Drug Manufacturing Facility 10/10/2025

   Ypsomed announced plans Oct. 9 to invest $195.4M in Holly Springs for its first North American manufacturing facility. The company will purchase and customize an existing 110,000-square-foot building in the YIELD Holly Springs. This purpose-built manufacturing campus is part of the broader Holly Springs Business Park, located just off N.C. 55. Ypsomed has committed to creating 62 high-quality jobs.

5. Lupin To Build New Drug Manufacturing Facility In Coral Springs, Florida 10/10/2025

   Global pharmaceutical leader, Lupin, today announced its plans for a new state-of-the-art pharmaceutical manufacturing plant in Coral Springs, a significant step in safeguarding the health and safety of Florida families and the nation.

6. Groninger Invests In The Future: Building A state-Of-The-Art Assembly Hall At Its Crailsheim Headquarters 10/8/2025

   groninger is expanding: A new assembly hall and adjoining office complex are being built, covering more than 75,000 square feet. With an investment volume of over 30 million euros, it marks the largest single investment in the company’s history.

7. TORL Biotherapeutics Secures $96M For ADC Drug Development From UCLA Lab 10/7/2025

   TORL BioTherapeutics LLC (TORL), a clinical stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend the lives of patients with cancer worldwide, today announced closing of a $96 million Series C financing. Additionally, updated results from the ongoing Phase 1 study of the Company's Claudin 6 (CLDN6) targeted antibody-drug conjugate (ADC) TORL-1-23 in patients with advanced cancer will be presented in poster sessions at the 2025 European Society of Medical Oncology Congress (ESMO 2025) in Berlin, Germany.

8. FDA Announces New ANDA Prioritization Pilot To Support U.S. Generic Drug Manufacturing And Testing 10/6/2025

   Today, the U.S. Food and Drug Administration (FDA) is announcing a new pilot prioritization program for the review of abbreviated new drug applications (ANDAs) that aims to spur and reward investment in U.S. drug manufacturing and research and development and strengthen the domestic pharmaceutical supply chain by providing faster reviews for generic companies who test and manufacture their products in the U.S.

9. groninger At CPHI 2025: Efficient, Flexible, Scalable 10/6/2025

   From October 28 to 30, 2025, the international pharmaceutical industry will gather in Frankfurt for CPHI – one of the most important global events in the sector. Among the exhibitors: groninger, a specialist in filling and closing systems, showcasing innovative machine solutions for processing pharmaceutical liquids in small and medium batch sizes. On the 130-square-meter exhibition space, visitors will experience firsthand how groninger responds to current industry demands with flexible and scalable machine concepts.

10. Eli Lilly To Invest $1B+ In India To Expand Global Drug Manufacturing And Supply 10/6/2025

    Eli Lilly (LLY.N) will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion.